For All The Latest Medical News, Health News, Research News, COVID-19 News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Cardiology News, Epigenetic News, Cancer News, Doctor News, Hospital News

✖
 ENGLISH
 ENGLISH  THAI
BREAKING NEWS
Source: Thailand Medical News  Jul 18, 2019  5 years, 4 months, 3 days, 16 hours ago

Study Shows Rituximab Effective For Treating Membranous Nephropathy

News
Study Shows Rituximab Effective For Treating Membranous Nephropathy
Source: Thailand Medical News  Jul 18, 2019  5 years, 4 months, 3 days, 16 hours ago
A recent clinical study  by Mayo Clinic in collaboration with Genetech, showed that Rituximab was just as effective at treating patients with membranous nephropathy at high risk for progressive disease, when compared with current conventional protocols which in most cases involves cyclosporine.



Rituximab demonstrated in inducing complete or partial remission of proteinuria at 12 months and is superior in maintaining proteinuria remission up to 24 months.

In the clinical study, 130 patients with membranous nephropathy were randomly assigned to receive either intravenous rituximab or oral cyclosporine.

The patients in the study were followed for 24 months, and had prior proteinuria of at least 5 g per 24 hours and a quantified creatinine clearance of at least 40 mL per minute per 1.73 m² of body surface area and had been receiving angiotensin-system blockade for at least 90 days.

The team from Mayo Clinic found that at 365 days, 39 of 65 patients (60 percent) in the rituximab group and 34 of 65 (52 percent) in the cyclosporine group had complete or partial remission  (risk difference, 8 percentage points; 95 percent confidence interval, −9 to 25; P = 0.004 for noninferiority). At 730 days, 39 patients (60 percent) in the rituximab group and 13 patients (20 percent) in the cyclosporine group had complete or partial remission (risk difference, 40 percentage points; 95 percent confidence interval, 25 to 55; P < 0.001 for both noninferiority and superiority). Among patients in remission who tested positive for anti-phospholipase A2 receptor (PLA2R) antibodies, the decline in autoantibodies to anti-PLA2R was faster and of greater magnitude and duration in the rituximab group than in the cyclosporine group.

Dr Fernando C. Fervenza, Ph.D, lead author commented in a phone interview with Thailand Medical News,"We found that rituximab was noninferior to cyclosporine in inducing proteinuria remission at 365 days and was superior in maintaining long-term proteinuria remission up to 730 days in patients with membranous nephropathy who were at high risk for progressive disease."

MOST READ

Nov 08, 2024  13 days ago
Nikhil Prasad
COVID-19 and the Hidden Threat of Cytomegalovirus (CMV) Reactivation
Nov 05, 2024  17 days ago
Nikhil Prasad
Study Reveals That COVID-19 Alters Key Human Genes
Oct 07, 2024  2 months ago
Nikhil Prasad
Study reveals the SARS-CoV-2 spike protein interacts with over 60,000 host proteins and may trigger carcinogenesis!
Aug 08, 2024  4 months ago
Nikhil Prasad
COVID-19 induced endothelial dysfunction will lead to a pandemic of chronic kidney and cardiovascular diseases
Aug 04, 2024  4 months ago
Nikhil Prasad
COVID-19's unexpected impact - Rising orofacial pain among infected individuals
Jul 25, 2024  4 months ago
Nikhil Prasad
Murine study shows how COVID-19 increases risk for stroke
Jul 24, 2024  4 months ago
Nikhil Prasad
COVID-19 can cause Osteomyelitis of the jaw
Jul 22, 2024  4 months ago
Nikhil Prasad
COVID-19 causes Blood DNA Methylation, a potential biomarker for Long COVID severity
Jul 22, 2024  4 months ago
Nikhil Prasad
Doctors from Turkey warns that children exposed to SARS-CoV-2 are at risk of acute kidney injury
Jul 08, 2024  5 months ago
Nikhil Prasad
Unknown To Many Including Doctors, COVID-19 Causes Parsonage Turner Syndrome
Jun 26, 2024  5 months ago
Nikhil Prasad
BREAKING! Mild COVID Causes A Slow Progressing Eye Debilitating Condition That Most Are Not Even Aware Of Till It's Too Late!
Jun 24, 2024  5 months ago
Nikhil Prasad
COVID-19's Hidden Impact on Eyes: Unveiling Rare Retinal Conditions
Jun 23, 2024  5 months ago
Nikhil Prasad
Somnolence And Shingles Seems To Be New Symptom/Manifestation Of COVID-19 KP.3 And LB.1 Infections!
Jun 22, 2024  5 months ago
Nikhil Prasad
Herbs And Phytochemicals: Fermented Codonopsis lanceolata Root Extract Shows Promise Against Influenza A Virus
Jun 12, 2024  5 months ago
Nikhil Prasad
Most Long COVID Patients Likely To Develop New Onset Psychiatric Disease!
Mar 12, 2024  8 months ago
Nikhil Prasad
Mild Or Moderate COVID-19 Causes Accelerated Brain Aging Especially In Young To Early Middle-Aged Adults!
Mar 10, 2024  9 months ago
Nikhil Prasad
Six Percent Of All Post-COVID Patients Who Have Hip Discomfort Likely To Have Developed Avascular Necrosis Of The Femoral Head!
Mar 05, 2024  9 months ago
Nikhil Prasad
Austrian Scientists Claim That High-Density Lipoproteins Can Be Used As Antivirals Against COVID-19 Infections
Feb 20, 2024  9 months ago
Nikhil Prasad
New Measles Variant That Can Evade Current Diagnostics Identified In Italy! More New Strains To Be Announced Soon!
Jan 02, 2024  11 months ago
Nikhil Prasad
BREAKING COVID-19 News! Study Claims That Omicron Infections Can Lead To Acute Primary Angle Closure And Also Primary Angle Closure Glaucoma!
Dec 16, 2023  11 months ago
Nikhil Prasad
BREAKING COVID-19 News! Australian Scientists Discover A microRNA Called CoV2-miR-O8 That Is Encoded By SARS-CoV-2 And Is Possibly Pathogenetic!
Dec 15, 2023  11 months ago
Nikhil Prasad
COVID-19 News: Foods Rich In XeSiAs-Neu5Gc Contributes To Xenosialylation That Causes Worse Outcomes In SARS-CoV-2 Infections And Vaccination!
Oct 23, 2023  1 year ago
Nikhil Prasad
COVID-19 News: SARS-CoV-2 Is Likely An Oncogenic Virus That Will Cause Lung, Colorectal, Oral, Pancreatic And Breast Cancers In The Long Term!
Jun 29, 2023  1 year ago
Medical News - SARS-CoV-2 - IGF2BP1
BREAKING! Scientists Warns That SARS-CoV-2 Also Interacts With IGF2BP1- An Oncofetal RNA-Binding Protein That Typically Fuels Tumor Virus Propagation!
Jun 10, 2023  1 year ago
COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
BREAKING NEWS! Even Asymptomatic SARS-CoV-2 Infections Cause DNA Methylation And Epigenetic Changes, Leading to Immune Dysregulation!
May 13, 2023  2 years ago
COVID-19 News - Viral Peristence - Long COVID
There Is No Such Thing As Long COVID! SARS-CoV-2 Exposure Causes Persistent Infections Along With Continuous Presence Of Short Viral RNAs (svRNAs)!
Feb 07, 2023  2 years ago
COVID-19 News - Breast Cancer
BREAKING! COVID-19 News: SARS-CoV-2 Infections Lead To Increased Risk Of Breast Cancer, Recurrence Of Breast Cancer And Also Breast Cancer Metastasis!
Nov 29, 2022  2 years ago
COVID-19 News - D-Alanine Supplements Prevents COVID-19 Severity
BREAKING COVID-19 News: Japanese Scientists Find That Supplementation With The Amino Acid D-Alanine Can Help Prevent And Treat COVID-19 Severity!
Sep 28, 2022  2 years ago
Source: Medical News - SARS-CoV-2 Reinfections - Omicron
Study Validates Previous Findings That SARS-CoV-2 Reinfections Are Now Occurring At Shorter Intervals. Current CDC and ECDC Reinfection Definitions Are Obsolete!
Aug 04, 2022  2 years ago
Source: Medical News - SARS-CoV-2 & Cancer
BREAKING! Study Finds That Cancer Causing Genes Are Upregulated In SARS-CoV-2 Infected Individuals!
Jun 27, 2022  2 years ago
Source: Medical News -SARS-CoV-2 Reduces Human Life Spans
BREAKING! Hypothesis That Majority Exposed To SARS-CoV-2 Will Have Shortened Lifespans Validated By Study Showing NSP2 Impairs Human 4EHP-GIGYF2 Complex!
Dec 25, 2021  3 years ago
Source: SARS-CoV-2 Viral Persistence
BREAKING! U.S. NIH Study Shockingly Reveals SARS-CoV-2 Viral Persistence Throughout Human Body And In The Brain Even In Those Who Were Asymptomatic!
Nov 18, 2021  3 years ago
Source: SARS-CoV-2-Cancer
BREAKING! New International Study Warns That SARS-CoV-2 Infections Will Lead To Cancers Especially Colorectal Cancers Due to Disruption In Autophagy!
Nov 13, 2020  4 years ago
Source: COVID-19 Genetics
BREAKING! COVID-19 Genetics: Yale Scientist Identify Eight ‘Super’ Genetic Variants In White People That Increases COVID-19 Death Risk!
Nov 05, 2020  4 years ago
Source: Ozone Water-COVID-19
Japanese Study Shows That Ozone Water Rapidly Inactivates SARS-Cov-2 Coronavirus, Making It An Ideal COVID-19 Disinfectant And Sanitizer
Sep 30, 2020  4 years ago
Source: BREAKING NEWS
BREAKING NEWS! COVID-19 Study Reveals That SARS-CoV-2 Uses CD4 Cells To Infect T-helper Lymphocytes. COVID-19 A Potent Version Of Airborne HIV?

FROM MEDICAL SCHOLARSHIPS / GRANTS

LATEST ON PREMIUM CONTENT

World COVID-19 News
COVID-19 Diagnostics
COVID-19 Drugs
COVID-19 Supplements
COVID-19 Herbs
COVID-19 Disinfectants
COVID-19 Mutations
COVID-19 Research
COVID News
Long COVID
COVID-19 Vaccines
COVID-19 Clinical Care
Medical Press Releases
Medical Innovations & Startups
AI in Medicine
Thailand Biotech News
Medical Spheres Bulletins
Medical White Papers
Medical Packages
Medical Tips
Medical Support Groups
Medical Tourism
TNM Aristrocrat Club
Medical Journals
Thai Herbal Products
TMN Medical Mart
Wellness Centers
Rehab Centers
Medsiam App